Improving outcomes for high-risk DLBCL: a pilot study looking at the role of fractionated cyclophosphamide with RCHOP chemo-immunotherapy (SCUBA-1 trial)

The outcomes for patients with high-risk DLBCL are suboptimal, especially in Low-middle income countries in comparison to published data from the western world. Most newer therapies aimed at improving outcomes are either unavailable or out of reach for the majority of patients in low-middle income c...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Charanpreet, Malhotra, Pankaj, Jandial, Aditya, Jain, Arihant, Lad, Deepesh, Khadwal, Alka, Bal, Amanjit, Das, Ashim, Mittal, BR, Prakash, Gaurav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441818/
https://www.ncbi.nlm.nih.gov/pubmed/36091934
http://dx.doi.org/10.1007/s12288-022-01562-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441818/
https://www.ncbi.nlm.nih.gov/pubmed/36091934
http://dx.doi.org/10.1007/s12288-022-01562-w

Ejemplares similares